B
BFRI
Biofrontera Inc
1.480
0.0000.00%After Hours: 1.480 0.000 0.00%16:10 08/21 EDT
OPEN/PREV CLOSE1.540/1.530
TODAY RANGE1.480-1.570
VOL387.60K
MARKET CAP22.13M
52 WEEK RANGE0.5547-1.600
AVG VOL (3M)389.62K
% TURNOVER2.61%
TURNOVER--
P/E (TTM)-2.5388
% RANGE5.88%
EPS(TTM)-0.5869
P/E(FORWARD)-3.8205
P/B3.554
BVPS0.4193
DIVIDEND--
P/S0.4162
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP18.43M
SHARES OUTSTANDING14.85M
NEXT EARNINGS11/10-11/16
FREE FLOAT12.37M
LOT SIZE1
EX-DATE07/05/2023
News
Press Releases
Financial Reports
Profile
NASDAQ·1d ago
Biotech Stocks Facing FDA Decision In September 2026
TipRanks·3d ago
Biofrontera Earnings Call Highlights Growth Amid Legal Risks
Seeking Alpha·08/13 19:13
Biofrontera GAAP EPS of -$0.05, revenue of $12M
NASDAQ·08/13 14:10
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates
Dow Jones·08/13 12:52
*Biofrontera 2Q Loss/Shr 5c >BFRI
Dow Jones·08/13 12:52
*Biofrontera 2Q Net Product Rev $12.0M >BFRI
NASDAQ·08/07 12:20
Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates
TipRanks·07/08 16:31
Biofrontera’s Acne PDT Trial Completion: What Investors Should Watch Next
TipRanks·07/07 16:30
Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors
TipRanks·06/17 21:29
Biofrontera Shareholders Approve Director Elections and Equity Plan
TipRanks·06/03 00:15
Biofrontera Earnings Call Highlights Growth And Risks
Benzinga·05/19 14:34
This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Benzinga·05/19 14:32
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday
TipRanks·05/19 13:35
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
Dow Jones·05/19 12:51
Biofrontera Price Target Maintained With a $3.00/Share by Benchmark
Same Industry
Name/Symbol
Change%
Price